Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Intermittent/cyclic etidronate 400 mg/day vs placebo

Hip Fracture · postmenopausal women at lower risk of fractures1

1 finding from 1 review

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Intermittent/cyclic etidronate 400 mg/day vs placebo

Hip Fracture · postmenopausal women with a higher risk for fracturesa

It is very uncertain whether intermittent/cyclic etidronate 400 mg/day changes hip fractures compared with placebo (very low certainty).

1 finding from 1 review

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women 2024 · Cochrane Headline outcomes only
RR 0.93 [0.17, 5.19]
Studies not reported
Very low